Abnormal expression of Hippo-YAP1 signalling pathway and progesterone resistance mechanism in endometrial polyps

被引:0
作者
Yu, Xinyu [1 ]
Kong, Weijia [1 ]
Shang, Kaiyue [1 ]
Xing, Hongxin [1 ]
Sun, Wenjing [2 ]
Li, Qianqian [3 ]
Zhang, Hui [1 ]
机构
[1] Shandong First Med Univ, Shandong Prov Hosp, Dept Obstet & Gynaecol, Jinan 250021, Shandong, Peoples R China
[2] Shandong Univ, Shandong Prov Hosp 3, Cheeloo Coll Med, Dept Obstet & Gynaecol, Jinan, Peoples R China
[3] Shandong First Med Univ, Jinan Matern & Child Care Hosp, Dept Obstet & Gynaecol, Jinan, Peoples R China
关键词
Hippo; YAP1; progesterone receptor; PRL; endometrial polyps; RECEPTOR EXPRESSION; ESTROGEN-RECEPTOR; ORGAN SIZE; YAP; CANCER;
D O I
10.1080/01443615.2025.2533965
中图分类号
R71 [妇产科学];
学科分类号
100211 ;
摘要
BackgroundEndometrial polyps (EPs) are a localised hyperproliferative disorder of the endometrium, and its pathogenesis remains unclear. Progesterone resistance may influence the recurrence rate of progesterone-treated EPs. Expression of the Hippo-YAP1 signalling pathway has been studied in various diseases. However, few studies have explored their expression in EPs and association with progesterone resistance. Prolactin (PRL), a molecular marker of endometrial mesenchymal cell metaplasia, indirectly reflects progesterone action in vivo. This study aimed to explore the role of Hippo-YAP1 signalling pathway in EPs.MethodsEndometrial tissue specimens obtained by surgical resection from 35 patients with a normal endometrium and 35 with EPs were collected between July 2023 and July 2024. Immunohistochemically, the expressions of mammalian STE20-like kinase 1 (MST1), Yes-associated protein 1 (YAP1), progesterone receptor (PR) and PRL in the normal endometrium and EPs tissues were detected.ResultsCompared to normal endometrial tissues, the expression of MST1 was relatively low in EPs (p < .05), while the total and nuclear expression of YAP1 was relatively high in EPs (p < .0001). The expression of PR in EPs tissues was significantly lower than that in normal endometrial tissues (p < .05), and the expression level of PRL was lower than that of normal endometrium in EPs tissues (p < .001).ConclusionsEPs have progesterone resistance, and the Hippo-YAP1 signalling pathway may be involved in the development and progression of EPs by acting on the progesterone resistance mechanism.
引用
收藏
页数:11
相关论文
共 39 条
[1]  
Ajongbolo A.O., Langhans S.A., YAP/TAZ-associated cell signalling–at the crossroads of cancer and neurodevelopmental disorders, Frontiers in Cell and Developmental Biology, 13, (2025)
[2]  
AAGL practice report: practice guidelines for the diagnosis and management of endometrial polyps, Journal of Minimally Invasive Gynaecology, 19, 1, pp. 3-10, (2012)
[3]  
Camargo F.D., Et al., YAP1 increases organ size and expands undifferentiated progenitor cells, Current Biology, 17, 23, pp. 2054-2060, (2007)
[4]  
Cordenonsi M., Et al., The Hippo transducer TAZ confers cancer stem cell-related traits on breast cancer cells, Cell, 147, 4, pp. 759-772, (2011)
[5]  
Fukuda K., Et al., Prognostic significance of progesterone receptor immunohistochemistry in endometrial carcinoma, Gynecologic Oncology, 69, 3, pp. 220-225, (1998)
[6]  
Gu C., Et al., Inhibiting the PI3K/Akt pathway reversed progestin resistance in endometrial cancer, Cancer Science, 102, 3, pp. 557-564, (2011)
[7]  
Jiang L., Et al., YAP‑mediated crosstalk between the Wnt and Hippo signaling pathways (review), Molecular Medicine Reports, 22, 5, pp. 4101-4106, (2020)
[8]  
Jiang P., Et al., Negative regulation of AMPK signalling by high glucose via E3 ubiquitin ligase MG53, Molecular Cell, 81, 3, pp. 629-637, (2021)
[9]  
Jiang Y., Et al., The efficacy of levonorgestrel intrauterine system, drospirenone & ethinylestradiol tablets (II) and dydrogesterone in preventing the recurrence of endometrial polyps, Archives of Gynecology and Obstetrics, 310, 3, pp. 1645-1649, (2024)
[10]  
Justice R.W., Et al., The Drosophila tumour suppressor gene warts encodes a homologue of human myotonic dystrophy kinase and is required for the control of cell shape and proliferation, Genes & Development, 9, 5, pp. 534-546, (1995)